{"id":1331,"date":"2012-07-04T18:50:01","date_gmt":"2012-07-04T18:50:01","guid":{"rendered":"https:\/\/drugpolicy.ca\/?p=1331"},"modified":"2015-04-04T20:36:17","modified_gmt":"2015-04-04T20:36:17","slug":"dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits","status":"publish","type":"post","link":"https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/","title":{"rendered":"Dr Mark Tyndall \u2013 Les centres d\u2019injection supervis\u00e9e sont le paratonnerre de la r\u00e9duction des m\u00e9faits"},"content":{"rendered":"<p>Je me suis entretenu avec le Dr Mark Tyndall au\u00a0 <a href=\"http:\/\/cahr-conference-acrv.ca\/fr\/index.html\" target=\"_blank\">21<sup>e<\/sup> Congr\u00e8s canadien annuel de recherche sur le VIH\/sida<\/a> (ACRV) \u00e0 Montr\u00e9al, en avril, dont le th\u00e8me \u00e9tait \u00ab\u00a0Un point tournant dans la lutte contre le VIH : de nouveaux d\u00e9fis \u00e0 relever\u00a0\u00bb. Relever des d\u00e9fis n\u2019a rien d\u2019inhabituel pour Tyndall, \u00e9tant reconnu comme leader national de la pr\u00e9vention et des soins du VIH. Il a travaill\u00e9 plus de dix ans \u00e0 Vancouver \u00e0 l\u2019UBC et au Centre d\u2019excellence de la Colombie-Britannique pour le VIH\/sida, et aussi comme chef des maladies infectieuses \u00e0 l\u2019h\u00f4pital St. Paul\u2019s. Il r\u00e9side maintenant \u00e0 Ottawa et est chef des <a href=\"http:\/\/thinkottawamedicine.ca\/divisions\/division-of-infectious-diseases\/leadership-members-in-infectious-diseases\/mark-tyndall-md-scd-frcpc\/\" target=\"_blank\">maladies infectieuses \u00e0 l\u2019Universit\u00e9 d\u2019Ottawa<\/a>.<\/p>\n<p><iframe loading=\"lazy\" src=\"http:\/\/www.youtube.com\/embed\/pVnCDkLk44Q\" width=\"560\" height=\"315\" frameborder=\"0\"><\/iframe><\/p>\n<blockquote><p>\u00ab les centres d\u2019injection supervis\u00e9e sont devenus le paratonnerre de la r\u00e9duction des m\u00e9faits, mais nous savons et reconnaissons tous qu\u2019ils sont un moyen tr\u00e8s important d\u2019essayer d\u2019int\u00e9grer les gens \u00e0 un genre de continuum de soins\u2026 et le besoin est encore tr\u00e8s vaste. \u00bb<\/p><\/blockquote>\n<p>Ayant \u00e9t\u00e9 en premi\u00e8re ligne du centre d\u2019injection supervis\u00e9e de Vancouver (INSITE), Tyndall sait que les centre d\u2019injection supervis\u00e9e et les <a href=\"http:\/\/dev.drugpolicy.ca\/fr\/solutions-innovatrices-2\/politiques-cl%c3%a9s\/accro%c3%aetre-la-r%c3%a9duction-des-m%c3%a9faits\/\">services de r\u00e9duction des m\u00e9faits doivent \u00eatre accrus<\/a>.<\/p>\n<p>Tyndall affirme qu\u2019il y a une crise de sant\u00e9 publique \u00e0 Ottawa, semblable dans certains cas \u00e0 ce qu\u2019il a vu \u00e0 Vancouver il y a dix ans. La grande question, selon lui, est de savoir s\u2019il nous faut r\u00e9p\u00e9ter le m\u00eame processus de recherche et faire beaucoup des m\u00eames erreurs, ou si nous pouvons apprendre de ce qui s\u2019est pass\u00e9 dans des endroits comme Vancouver, Francfort et Sydney, et mettre en \u0153uvre efficacement des centres de r\u00e9duction des m\u00e9faits et d\u2019injection supervis\u00e9e. Tyndall \u00e9tait l\u2019invit\u00e9 d\u2019une <a href=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2012\/04\/Communiquer-de-presse-CACTUS-CDPC-Dr-Peter-AIDS-Fdn-Fr-Apr-19-3.pdf\" target=\"_blank\">conf\u00e9rence de presse tenue \u00e0 Montr\u00e9al<\/a> durant le congr\u00e8s de l\u2019ACRV qui envisageait des centres d\u2019injection \u00e0 l\u2019\u00e9chelle nationale, et il a \u00e9galement collabor\u00e9 au rapport sur la strat\u00e9gie de consommation supervis\u00e9e des drogues de Toronto\u00a0que nous avons r\u00e9dig\u00e9 au printemps dernier. <a title=\"Take action\" href=\"https:\/\/drugpolicy.ca\/fr\/passez-%C3%A0-laction\/ajoutez-votre-voix-et-aidez-a-ecrire-lhistoire\/\" target=\"_blank\">Veuillez vous joindre \u00e0 nous<\/a> et \u00e9crire vos commentaires pour nous dire ce que vous croyez qu\u2019il devrait \u00eatre fait dans votre communaut\u00e9.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Je me suis entretenu avec le Dr Mark Tyndall au\u00a0 21e Congr\u00e8s canadien annuel de recherche sur le VIH\/sida (ACRV) \u00e0 Montr\u00e9al, en avril, dont le th\u00e8me \u00e9tait \u00ab\u00a0Un point tournant dans la lutte contre le VIH : de nouveaux d\u00e9fis \u00e0 relever\u00a0\u00bb. Relever des d\u00e9fis n\u2019a rien d\u2019inhabituel pour Tyndall, \u00e9tant reconnu comme leader [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2892,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","footnotes":""},"categories":[7],"tags":[],"class_list":["post-1331","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee"],"acf":[],"mb":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dr Mark Tyndall \u2013 Les centres d\u2019injection supervis\u00e9e sont le paratonnerre de la r\u00e9duction des m\u00e9faits - Canadian Drug Policy Coalition<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dr Mark Tyndall \u2013 Les centres d\u2019injection supervis\u00e9e sont le paratonnerre de la r\u00e9duction des m\u00e9faits - Canadian Drug Policy Coalition\" \/>\n<meta property=\"og:description\" content=\"Je me suis entretenu avec le Dr Mark Tyndall au\u00a0 21e Congr\u00e8s canadien annuel de recherche sur le VIH\/sida (ACRV) \u00e0 Montr\u00e9al, en avril, dont le th\u00e8me \u00e9tait \u00ab\u00a0Un point tournant dans la lutte contre le VIH : de nouveaux d\u00e9fis \u00e0 relever\u00a0\u00bb. Relever des d\u00e9fis n\u2019a rien d\u2019inhabituel pour Tyndall, \u00e9tant reconnu comme leader [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta property=\"article:published_time\" content=\"2012-07-04T18:50:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2015-04-04T20:36:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/backup.drugpolicy.ca\/wp-content\/uploads\/2012\/03\/CDPC_MarkTyndall_Blog_415x415px-S-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"415\" \/>\n\t<meta property=\"og:image:height\" content=\"415\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/dfa227f7f7fb3d70383391c4c01ec657\"},\"headline\":\"Dr Mark Tyndall \u2013 Les centres d\u2019injection supervis\u00e9e sont le paratonnerre de la r\u00e9duction des m\u00e9faits\",\"datePublished\":\"2012-07-04T18:50:01+00:00\",\"dateModified\":\"2015-04-04T20:36:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\\\/\"},\"wordCount\":399,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2012\\\/03\\\/CDPC_MarkTyndall_Blog_415x415px-S-1.jpg\",\"articleSection\":[\"Non classifi\u00e9(e)\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\\\/\",\"name\":\"Dr Mark Tyndall \u2013 Les centres d\u2019injection supervis\u00e9e sont le paratonnerre de la r\u00e9duction des m\u00e9faits - Canadian Drug Policy Coalition\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2012\\\/03\\\/CDPC_MarkTyndall_Blog_415x415px-S-1.jpg\",\"datePublished\":\"2012-07-04T18:50:01+00:00\",\"dateModified\":\"2015-04-04T20:36:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\\\/#primaryimage\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2012\\\/03\\\/CDPC_MarkTyndall_Blog_415x415px-S-1.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2012\\\/03\\\/CDPC_MarkTyndall_Blog_415x415px-S-1.jpg\",\"width\":415,\"height\":415},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dr Mark Tyndall \u2013 Les centres d\u2019injection supervis\u00e9e sont le paratonnerre de la r\u00e9duction des m\u00e9faits\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"name\":\"Canadian Drug Policy Coalition\",\"description\":\"Change policy. Save lives.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Drug Policy Coalition\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"width\":332,\"height\":333,\"caption\":\"Canadian Drug Policy Coalition\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/dfa227f7f7fb3d70383391c4c01ec657\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/fr\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dr Mark Tyndall \u2013 Les centres d\u2019injection supervis\u00e9e sont le paratonnerre de la r\u00e9duction des m\u00e9faits - Canadian Drug Policy Coalition","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/","og_locale":"fr_FR","og_type":"article","og_title":"Dr Mark Tyndall \u2013 Les centres d\u2019injection supervis\u00e9e sont le paratonnerre de la r\u00e9duction des m\u00e9faits - Canadian Drug Policy Coalition","og_description":"Je me suis entretenu avec le Dr Mark Tyndall au\u00a0 21e Congr\u00e8s canadien annuel de recherche sur le VIH\/sida (ACRV) \u00e0 Montr\u00e9al, en avril, dont le th\u00e8me \u00e9tait \u00ab\u00a0Un point tournant dans la lutte contre le VIH : de nouveaux d\u00e9fis \u00e0 relever\u00a0\u00bb. Relever des d\u00e9fis n\u2019a rien d\u2019inhabituel pour Tyndall, \u00e9tant reconnu comme leader [&hellip;]","og_url":"https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/","og_site_name":"Canadian Drug Policy Coalition","article_published_time":"2012-07-04T18:50:01+00:00","article_modified_time":"2015-04-04T20:36:17+00:00","og_image":[{"width":415,"height":415,"url":"https:\/\/backup.drugpolicy.ca\/wp-content\/uploads\/2012\/03\/CDPC_MarkTyndall_Blog_415x415px-S-1.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/#article","isPartOf":{"@id":"https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/"},"author":{"name":"admin","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/dfa227f7f7fb3d70383391c4c01ec657"},"headline":"Dr Mark Tyndall \u2013 Les centres d\u2019injection supervis\u00e9e sont le paratonnerre de la r\u00e9duction des m\u00e9faits","datePublished":"2012-07-04T18:50:01+00:00","dateModified":"2015-04-04T20:36:17+00:00","mainEntityOfPage":{"@id":"https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/"},"wordCount":399,"commentCount":0,"publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/#primaryimage"},"thumbnailUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2012\/03\/CDPC_MarkTyndall_Blog_415x415px-S-1.jpg","articleSection":["Non classifi\u00e9(e)"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/","url":"https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/","name":"Dr Mark Tyndall \u2013 Les centres d\u2019injection supervis\u00e9e sont le paratonnerre de la r\u00e9duction des m\u00e9faits - Canadian Drug Policy Coalition","isPartOf":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/#primaryimage"},"image":{"@id":"https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/#primaryimage"},"thumbnailUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2012\/03\/CDPC_MarkTyndall_Blog_415x415px-S-1.jpg","datePublished":"2012-07-04T18:50:01+00:00","dateModified":"2015-04-04T20:36:17+00:00","breadcrumb":{"@id":"https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/#primaryimage","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2012\/03\/CDPC_MarkTyndall_Blog_415x415px-S-1.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2012\/03\/CDPC_MarkTyndall_Blog_415x415px-S-1.jpg","width":415,"height":415},{"@type":"BreadcrumbList","@id":"https:\/\/drugpolicy.ca\/fr\/dr-mark-tyndall-les-centres-dinjection-supervisee-sont-le-paratonnerre-de-la-reduction-des-mefaits\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drugpolicy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Dr Mark Tyndall \u2013 Les centres d\u2019injection supervis\u00e9e sont le paratonnerre de la r\u00e9duction des m\u00e9faits"}]},{"@type":"WebSite","@id":"https:\/\/www.drugpolicy.ca\/fr\/#website","url":"https:\/\/www.drugpolicy.ca\/fr\/","name":"Canadian Drug Policy Coalition","description":"Change policy. Save lives.","publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drugpolicy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization","name":"Canadian Drug Policy Coalition","url":"https:\/\/www.drugpolicy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","width":332,"height":333,"caption":"Canadian Drug Policy Coalition"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/dfa227f7f7fb3d70383391c4c01ec657","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/drugpolicy.ca\/fr\/author\/admin\/"}]}},"mfb_rest_fields":["title","yoast_head","yoast_head_json"],"_links":{"self":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/1331","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/comments?post=1331"}],"version-history":[{"count":0,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/1331\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media\/2892"}],"wp:attachment":[{"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media?parent=1331"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/categories?post=1331"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugpolicy.ca\/fr\/wp-json\/wp\/v2\/tags?post=1331"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}